[Kidney transplantation: indications, results, limitations, and perspectives].
In France, kidney transplantation is part of - and is reimbursed as - treatment for chronic kidney disease. Long-term survival and quality of life are better for transplant recipients than for dialysis patients. Stagnation in the survival rate of transplants over the past 10 years has led to the development of new immunosuppressive drugs to minimize the use of corticosteroids and anticalcineurins and to induce tolerance of the transplanted kidney. The scarcity and lower quality of kidneys for transplantation is also leading to the development of new transplantation sources: donors with cardiac arrest and elderly, living and ABO-incompatible donors.
Matignon
Marie
M
Service de néphrologie-transplantation, Hôpital Henri Mondor, Créteil.
Dahan
Karine
K
Fruchaud
Ghislaine
G
Audard
Vincent
V
Grimbert
Philippe
P
Lang
Philippe
P
D006323:Heart Arrest; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000401:mortality / Q000601:surgery*; D016030:Kidney Transplantation; D014019:Tissue Donors; D023001:Transplantation Tolerance
D007166:Immunosuppressive Agents